Abstract PO2-04-08: Translational insights from a phase 1, first-in-human (FIH) clinical trial of the anti-HER2 CAR macrophage CT-0508 in participants with HER2 positive metastatic breast cancer and other HER2 overexpressing solid tumors
Year: 2024
Type: conference-abstract
Source: Cancer Research
Authors: Yara Abdou, Joanne Mortimer, Paula Pohlmann, Melissa Johnson, Richard Maziarz, Jennifer M. Specht, Claire Dees, Naoto Ueno, Yuan Yuan, Mathew Angelos, Saar Gill, Olga Shestova, Jonathon Serody, Saul Priceman, Rehman Qureshi, Poonam Sonawane, Stefano Pierini, Maria Cecilia Oliveira-Nunes, Daniel Cushing, Michael Klichinsky, Thomas Condamine, Ramona Swaby, Kim Reiss
Institutions: University of North Carolina at Chapel Hill, City Of Hope National Medical Center, City of Hope, The University of Texas MD Anderson Cancer Center, Tennessee Oncology, Oregon Health & Science University, OHSU Knight Cancer Institute, University of Washington, Fred Hutch Cancer Center, University of Hawaii Cancer Center, Cedars-Sinai Medical Center, University of Pennsylvania, UNC Lineberger Comprehensive Cancer Center, Carisma Therapeutics (United States)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4396599575